Injectable combination of adrenergic receptor agonists with fillers, for decreasing skin reactions due to injection
US9050246B2 · kind B2 · utility
11Cited by
1References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 28, 2010 |
| Grant date | Jun 9, 2015 |
| Priority date | — |
| Expiry date | May 28, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61L2400/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention concerns an injectable composition comprising a filler or a botulinum toxin and an adrenergic receptor agonist, and its use for diminishing, decreasing or avoiding skin reactions due to injection, specially redness, ecchymosis, bruising, bleeding, erythema, oedema, necrosis, ulceration, swelling and/or inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.